Tela Bio Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +75.3% | +149.5% | +27.3% | -27.7% | +8.5% | +15.0% | +11.9% | -6.8% | |
| – | +62.1% | +176.7% | +29.4% | -29.0% | +5.7% | +14.9% | +8.8% | -3.2% | |
| – | +52.3% | +162.2% | +64.2% | -40.9% | -4.4% | +11.2% | +12.7% | -3.5% | |
| – | +52.3% | +215.9% | +36.3% | -40.9% | -4.4% | +11.2% | +12.7% | -3.5% | |
| – | +71.5% | +118.5% | -5.4% | +57.8% | +56.4% | +47.1% | +3.7% | +2.5% | |
| – | +139.6% | +5.9% | -15.1% | +96.0% | +54.0% | +11.6% | -2.9% | -13.8% | |
| – | -34.7% | -10.7% | -7.5% | +89.5% | +41.8% | – | – | – | |
| – | – | -9.5% | -10.4% | -11.7% | +8.5% | -15.2% | -17.9% | -21.9% | |
| – | +33.5% | -77.6% | +1.3% | +13.4% | +26.2% | +10.5% | -0.5% | +27.6% | |
| – | +55.5% | -29.8% | -1.6% | +60.1% | +17.3% | +36.8% | -8.1% | +15.2% | |
| – | – | – | – | – | – | +66.2% | -3.5% | – | |
| – | +127.0% | -7.3% | -79.4% | +270.2% | -36.5% | +8.7% | +28.8% | +7.5% | |
| – | +723.6% | +1.7% | +1.9% | +2.2% | +26.8% | +1.5% | +1.5% | +35.3% | |
| – | – | – | +58.3% | -59.0% | -28.8% | +32.0% | +50.7% | -77.8% | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +75.8% | +13.4% | +11.9% | +12.4% | +40.6% | +24.7% | +64.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.